APTOCROM Inc. (KOSDAQ:109960)
South Korea flag South Korea · Delayed Price · Currency is KRW
270.00
+3.00 (1.12%)
At close: Dec 5, 2025

APTOCROM Company Description

APTOCROM Inc. distributes pharmaceutical products in South Korea.

It offers prescription and over-the-counter medication, such as antibiotics, antifungal agent, antiviral drugs, infusion solution, peptic ulcer medication, osteoarthritis treatment, purifying solvent, brain function improvement agent, respiratory solvent, topical medicine, adrenocorticosteroids, urinary medicine, hair loss treatment, antipyretic analgesic and anti-inflammatory agent, antihistamines, obesity agents, neural contract, liver extract, fire extinguisher solvent, etc. The company was formerly known as AP Healthcare Inc. and changed its name to APTOCROM Inc. in September 2025.

APTOCROM Inc. was founded in 1998 and is headquartered in Seongnam-si, South Korea.

APTOCROM Inc.
Country South Korea
Founded 1998
Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Employees 14
CEO Hui Chang

Contact Details

Address:
Halla Sigma Valley B1
Seongnam-si
South Korea
Phone 82 31 8022 0595
Website aprogen-hng.com

Stock Details

Ticker Symbol 109960
Exchange KOSDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency KRW
SIC Code 5122

Key Executives

Name Position
Hui Chang Chief Executive Officer